Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates (Q33410972)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase I clinical trial

0 references

chemoradiotherapy

0 references

author name string

Janelle M Meyer

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kelly S Perlewitz

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

James B Hayden

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yee-Cheen Doung

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Arthur Y Hung

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

John T Vetto

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rodney F Pommier

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Atiya Mansoor

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Brooke R Beckett

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alina Tudorica

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Motomi Mori

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Megan L Holtorf

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Aneela Afzal

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

William J Woodward

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Eve T Rodler

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Robin L Jones

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wei Huang

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Christopher W Ryan

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

16 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6902-6911

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Phase 2 Southwest Oncology Group‐directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

The role of targeted agents in preoperative chemoradiation for rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Angiogenesis and antiangiogenic approaches to sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

21 June 2018

Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

31 October 2018

Localized Extremity Soft Tissue Sarcoma: Improved Knowledge With Unchanged Survival Over Time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3869565

31 October 2018

Sarcoma of soft tissue: Clinical and histopathologic parameters and response to treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24132922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24132922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy for soft-tissue sarcomas of the extremities

1 reference

https://pubmed.ncbi.nlm.nih.gov/24132922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ distribution of the beta-subunit of platelet-derived growth factor receptor in nonneoplastic tissue and in soft tissue tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24132922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins

1 reference

https://pubmed.ncbi.nlm.nih.gov/24132922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative therapy for soft tissue sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24132922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24132922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-13-1863

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33410972&oldid=1963992421"